Sanitas
Revista arbitrada de ciencias de la salud
Vol. 3(Enfermería Ambato UNIANDES), 101-108, 2024
Intervenciones según la taxonomía NIC en recién nacido con exposición perinatal al VIH.
Revisión sistemática
Interventions according to the NIC taxonomy in newborns with perinatal exposure to HIV.
Systematic review
Jomahe Nicole Sarmiento-Angulo
María Belén López-Garcés
Nicole Pamela Nuñez-Nuñez
Estefano Jordano Parreño-Moreno
108
8. du Toit LDV, Prinsloo A, Steel HC, Feucht U, Louw R, Rossouw TM. Immune
and Metabolic Alterations in Children with Perinatal HIV Exposure. Viruses.
2023;15(2):279. Published 2023 Jan 18. doi:10.3390/v15020279
9. Marcu EA, Dinescu SN, Pădureanu V, Dumitrescu F, Diaconu R. Perinatal
Exposure to HIV Infection: The Experience of Craiova Regional Centre,
Romania. Healthcare (Basel). 2022;10(2):308. Published 2022 Feb 6.
doi:10.3390/healthcare10020308
10. Hurst SA, Appelgren KE, Kourtis AP. Prevention of mother-to-child
transmission of HIV type 1: the role of neonatal and infant prophylaxis. Expert
Rev Anti Infect Ther. 2015;13(2):169-181.
doi:10.1586/14787210.2015.999667
11. Saint-Lary L, Benevent J, Damase-Michel C, Vayssière C, Leroy V, Sommet
A. Adverse perinatal outcomes associated with prenatal exposure to
protease-inhibitor-based versus non-nucleoside reverse transcriptase
inhibitor-based antiretroviral combinations in pregnant women with HIV
infection: a systematic review and meta-analysis. BMC Pregnancy Childbirth.
2023;23(1):80. Published 2023 Jan 30. doi:10.1186/s12884-023-05347-5
12. Onyia NE, Akhigbe P, Osagie E, et al. Prevalence and associated factors of
enamel developmental defects among Nigerian children with perinatal HIV
exposure. J Clin Pediatr Dent. 2023;47(2):1-9. doi:10.22514/jocpd.2023.007
13. Osmundo GS Junior, da Costa RA, Ruocco RMA, Francisco RPV. Pregnancy
in women living with perinatally acquired HIV: Perinatal outcomes and drug
resistance profile. Clinics (Sao Paulo). 2023;78:100174. Published 2023 Mar
2. doi:10.1016/j.clinsp.2023.100174
14. Zhang H, Hindman JT, Lin L, et al. A study of the pharmacokinetics, safety,
and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically
suppressed pregnant women with HIV. AIDS. 2024;38(1):F1-F9.
doi:10.1097/QAD.0000000000003783
15. Mandelbrot L, Tubiana R, Frange P, et al. Maintenance darunavir/ritonavir
monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168
MONOGEST study. J Antimicrob Chemother. 2023;78(7):1711-1722.
doi:10.1093/jac/dkad161
Derechos de autor: 2024 Por los autores. Este artículo es de acceso abierto y distribuido
según los términos y condiciones de la licencia Creative Commons Atribución-NoComercial-
CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
https://creativecommons.org/licenses/by-nc-sa/4.0/